Protalix BioTherapeutics Competitors and Similar CompaniesClear all
Protalix BioTherapeutics's competitors and similar companies include iBio and UCB.
 Protalix BioTherapeutics Protalix is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 1994 | Founding Date 2008 | Founding Date 1928 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Karmiel, IL HQ | Locations San Diego, US HQ Bryan, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 213 | Employees 1630% decrease | Employees 9,052 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 26.2 m | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $52.7m (FY, 2025) | Revenue (est.) $400k (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $25.5m (FY, 2025) | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $27.2m (FY, 2025) | Gross profit N/A | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($6.6m) (FY, 2025) | Net income N/A | Net income €1.6b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 62.5m | Total funding raised $ 9.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company